Related Experiment Video
Updated: Nov 18, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Updated overview on the interplay between obesity and COVID-19
Diletta Onorato1, Giovanni Carpenè1, Giuseppe Lippi1
1Section of Clinical Biochemistry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Overweight and obesity are linked to severe COVID-19 outcomes. Obese patients face a higher risk of critical illness, intensive care unit admission, and death from coronavirus disease 2019.
Area of Science:
- Public Health
- Epidemiology
- Clinical Medicine
Background:
- The global spread of coronavirus disease 2019 (COVID-19) has led to a significant health crisis.
- Emerging evidence suggests a potential link between overweight/obesity and COVID-19 severity.
Purpose of the Study:
- To review the scientific literature on the impact of overweight and/or obesity in hospitalized patients with severe or critical COVID-19.
- To synthesize findings on the association between obesity and adverse COVID-19 outcomes.
Main Methods:
- Systematic literature search following PRISMA guidelines.
- Keywords used: "obesity" and "COVID-19".
- Selection of 22 articles from over 300 identified, focusing on those reporting risk estimates for obesity and COVID-19 severity.
Main Results:
- A significant association was found between obesity and increased risk of severe COVID-19 illness in most reviewed studies.
- In 79% of studies providing a risk estimate (odd ratio; OR), the OR for obesity and severe disease was >2.
- Obesity was linked to higher rates of intensive care unit admission and death.
Conclusions:
- Increased body mass index is a negative prognostic factor for COVID-19 patients.
- Overweight and obese individuals may require more aggressive prevention and treatment strategies for COVID-19.
More Related Videos
06:28A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
Published on: April 28, 2023
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Drug Dosing: Obese Patients
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...